TS
VC

TVM Capital Life Science

United Statestvm-capital.com

TVM Capital Life Science is a venture capital firm based in the United States, investing in Healthcare & Life Sciences, Nanotechnology and Pharmatech, 4 tracked investments.

4
Investments Tracked

About TVM Capital Life Science

TVM Capital Life Science is a venture capital firm based in the United States. Brouky tracks 4 investments associated with the firm.

TVM Capital Life Science invests across Healthcare & Life Sciences, Nanotechnology, Pharmatech and Medical Diagnostics. Coverage extends to 8 sectors in total. Participation spans Series B and Series C+ rounds.

TVM Capital Life Science invests in early-stage therapeutics through single asset companies and commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics. They focus on first-in-class or best-in-class assets with the potential to transform the standard of care.

Investment Focus

Stage Focus
series-bseries-c-plus
Sectors
Healthcare & Life SciencesnanotechnologypharmatechMedical DiagnosticsHealthcare TechMedical Devicegmp-manufacturinglipid-nanoparticles

Investment Thesis

TVM Capital Life Science invests in early-stage therapeutics through single asset companies and commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics. They focus on first-in-class or best-in-class assets with the potential to transform the standard of care.

Team

Dr. Hubert BirnerManaging Partner

Responsible for TVM Capital Life Science's overall investment strategy and global fund operations. Chairman of leon nanodrugs GmbH and AL-S Pharma AG.

Stefan FischerManaging Partner (Finance)

CFO since 2012. Holds overall advisory responsibility for finance operations of firm's offices in Europe and North America. More than 23 years of venture capital experience.

Dr. Luc MarengèreManaging Partner

Joined TVM in 2012. Responsible for overall investment strategy and global fund operations. More than 25 years of venture capital experience.

Dr. Valentina AgostoniPrincipal

Joined TVM in 2020. Hands-on experience in preclinical drug development from hit identification to IND-enabling studies. PhD in Biopharmacy.

Luisa Susanna HaertelJunior Analyst

Joined TVM in June 2023. Graduate-entry medical student. Previously supported early-stage VC teams at YZR Capital and Mountain Partners.

Barbara HauserSenior Accountant
Mechthild HeinemannOffice Administration
Amy KaoSenior Associate

Joined TVM in April 2023. Previously at Oxford Science Enterprises building healthtech opportunities. DPhil in Neuroscience from University of Oxford.

Paul KoflerAnalyst

Medical student passionate about creating value for patients. Supports executive team with deal-flow screening, research and due diligence.

Dominique LaroseAssistant to Montreal Team
Philipp LechnerPrincipal

Joined TVM in 2020. Previously worked for Global Healthcare Team at Société Générale Corporate & Investment Banking on M&A transactions.

Monika MarosevicAccountant

Explore TVM Capital Life Science's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Nanotechnology